Skip to main content
Premium Trial:

Request an Annual Quote

Sanger Centre Launches Cancer Genome Project

Premium

HINXTON, UK--The Sanger Centre said it has secured £10 million from the Wellcome Trust to set up a Cancer Genome Project that will use data from the human genome project to identify gene abnormalities associated with all forms of human cancers. Michael Stratton and Richard Wooster of the Institute of Cancer Research will lead the project, to be based at Sanger. The two scientists are known for discovering the BRCA2 gene in 1995.

The project "will be one of the first examples of how the complete information emerging from the Human Genome Project can be used in understanding human disease," the center noted, adding that advances made through the cancer project would affect study of other human diseases such as heart disease and diabetes.

Project leaders said they would make use of the entire human sequence data generated by the Sanger Centre together with very high-throughput mutation detection techniques to adopt a global and systematic approach to identifying cancer genes.

Filed under

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.